Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

InstaRX vs NuvaHealth

InstaRX
Graded #250

Lower grade

vs+10.400000000000006
NuvaHealth
Graded #65

Higher grade

The verdict

NuvaHealth takes it — 74.2/100 to 63.8/100.

NuvaHealth grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. NuvaHealth (nuvahealth.org) is a LegitScript-certified compounded GLP-1 telehealth platform offering compounded semaglutide starting at $159 first-month and compounded tirzepatide starting at $259 first-month.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNuvaHealth +16
60
76
Dose & formulationNuvaHealth +24
64
88
Clinical oversightNuvaHealth +10
72
82
Labs & monitoringNuvaHealth +1
52
53
FulfillmentInstaRX +4
78
74
Contract termsEven
55
55
InstaRX · left barNuvaHealth · right bar

The numbers

MetricInstaRXNuvaHealth
WeighScore63.8/10074.2/100
GradeCC
Scorecard rank#250#65
Semaglutide$199/mo (starting dose, compounded)$139/mo (first-month rate, compounded)
Tirzepatide$199/mo (starting dose, compounded)$229/mo (first-month rate, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyYes
InstaRX

Graded #250 · C

Strengths

  • Available in all 50 states plus DC
  • Manage GLP-1, anti-aging peptides, and sexual-health medications on one account
  • Offers both compounded semaglutide and compounded tirzepatide
  • Independent provider group (Dr Telx) named in the Terms of Service

Where it loses points

  • No per-dose or monthly pricing published — only a "$199 to get started" hook; you can't compare costs before intake
  • No LegitScript, HIPAA, or NABP accreditation shown on public pages
  • Compounding pharmacy not named — only "U.S. pharmacies"
  • Terms of Service reads like generic boilerplate, including copy-paste language about women's health issues — suggests low template hygiene
  • Delaware governing law for disputes despite a California corporate address
NuvaHealth

Graded #65 · C

Strengths

  • LegitScript Certified seal displayed on the marketing site (the standard third-party telehealth/pharmacy accreditation)
  • Free and fast delivery + 24/7 patient support disclosed on the home page
  • Newark, DE address suggests a US-incorporated entity (vs offshore)
  • $139 first-month price for compounded semaglutide injection is among the cheapest in the US compounded telehealth market
  • $229 first-month price for compounded tirzepatide injection sits in the lower-median range

Where it loses points

  • Standard ongoing monthly price NOT publicly disclosed (gated behind checkout) — patients should ask for the maintenance-dose price before committing
  • Specific legal entity name + state of incorporation NOT publicly disclosed on the home page — material YMYL transparency gap
  • Pharmacy partners NOT publicly named — material YMYL transparency gap
  • Per-state availability NOT enumerated; verify your state ships before purchase
  • Lab work + coaching support NOT publicly disclosed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard